|Year : 2020 | Volume
| Issue : 2 | Page : 86-89
Clinical features and molecular genetics of autosomal recessive ataxia in the Turkish population
Faruk Incecik1, Ozlem M Herguner1, Neslihan O Mungan2
1 Department of Pediatric Neurology, Faculty of Medicine, Cukurova University, Adana, Turkey
2 Department of Pediatric Metabolism and Nutrition, Faculty of Medicine, Cukurova University, Adana, Turkey
|Date of Submission||25-Sep-2018|
|Date of Decision||18-Nov-2019|
|Date of Acceptance||06-Dec-2019|
|Date of Web Publication||30-Jun-2020|
Dr. Faruk Incecik
Department of Pediatric Neurology, Faculty of Medicine, Cukurova University, Toros mah. 78186 sok., Yeşilpark Evleri, Kat: 7, No: 13, Adana.
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Autosomal recessive cerebellar ataxias (ARCAs) are a heterogeneous group of inherited neurodegenerative disorders. The aim of this study was to present the clinical and genetic features of patients with ataxia complaints and those genetically diagnosed with ARCAs. Materials and Methods: Thirty-one children with ARCA were retrospectively analyzed. Results: Fourteen (45.2%) were boys and 17 (54.8%) were girls with the mean age at onset of symptoms of 46.13 ± 26.30 months (12–120 months). Of the 31 patients, 21 (67.7%) were from consanguineous marriages. Eight patients had Friedreich’s ataxia, five had ataxia telangiectasia, three had l-2-hydroxyglutaric aciduria, three had Joubert syndrome, two had neuronal ceroid lipofuscinosis, two had megalencephalic leukoencephalopathy with subcortical cysts, two had ataxia with ocular motor oculomotor apraxia type 1, one had cytochrome c oxidase deficiency, one had autosomal recessive spastic ataxia of Charlevoix-Saguenay, one had Niemann-Pick type C, one had congenital disorders of glycosylation, one had adrenoleukodystrophy, and one had cobalamin transport disorder. Conclusion: The prevalence of hereditary ataxia can vary among countries. The consanguineous marriage is an important finding in these diseases. These genetic tests will increase the number of ARCA patients diagnosed.
Keywords: Clinical findings, genetic study, hereditary ataxia
|How to cite this article:|
Incecik F, Herguner OM, Mungan NO. Clinical features and molecular genetics of autosomal recessive ataxia in the Turkish population. J Pediatr Neurosci 2020;15:86-9
| Introduction|| |
The hereditary ataxias are a clinically and genetically heterogeneous group of disorders characterized by slowly progressive incoordination of gait and are often associated with poor coordination of hands, speech, and eye movements. Frequently, atrophy of the cerebellum occurs.
The hereditary ataxias are categorized by mode of inheritance and gene in which causative mutations occur, or chromosomal locus. The hereditary ataxias can be inherited in an autosomal dominant, autosomal recessive, X-linked manner, or through maternal inheritance if part of a mitochondrial genetic syndrome. The genetic forms of ataxia are diagnosed by family history, physical examination, neuroimaging, and molecular genetic testing.
Autosomal recessive cerebellar ataxias (ARCAs) are a heterogeneous group of inherited neurodegenerative disorders that affect the cerebellum, the spinocerebellar tract, and/or the sensory tracts of the spinal cord. They are characterized by prominent progressive cerebellar ataxia in association with other neurological or extra-neurological signs.,, Friedreich’s ataxia (FRDA) and ataxia telangiectasia (AT) are known to be the two most frequent forms of ARCAs.,
To the best of our knowledge, very few studies related to ARCAs in childhood have been conducted. We presented the characteristics of the patients who came with ataxia complaints and detected ARCA.
| Materials and Methods|| |
Patients with ataxia complaints and genetic diagnosis were included in the study. This was a retrospective study of 31 children diagnosed with ARCAs, which was conducted at Cukurova University Hospital, Adana, Turkey, between 2012 and 2018. We reviewed clinical examination and laboratory, imaging, electrophysiological, and molecular investigations.
The data were retrospectively collected from the clinic files and included sex, age, age at onset of symptoms; stage of mental and motor development before the onset of symptoms; family history; consanguinity; presence of microcephaly or macrocephaly; mental retardation; deep tendon reflexes; seizures; polyneuropathy; cerebral magnetic resonance imaging (MRI) findings; levels of serum α-fetoprotein, vitamin E, vitamin B12, lipids; the results of metabolic tests, and enzymes for lysosomal and peroxisomal disorders; and genetic analysis. Acquired and autosomal dominant ataxias were excluded.
On the basis of MRI findings, patients were grouped into three categories: those with normal or nonspecific findings, those with cerebellar atrophy only, and those with cerebellar atrophy combined with other changes.
| Results|| |
Twenty-nine children, mean age 105.32 ± 33.70 months (19–180 months), were included in this study. Among the 31 patients, 14 (45.2%) were boys and 17 (54.8%) were girls, and the mean age at onset of symptoms was 46.13 ± 26.30 months (12–120 months).
Eight patients had Friedreich’s ataxia (FRDA), five had AT, three had l-2-hydroxyglutaric aciduria, three had Joubert syndrome (JS), two had neuronal ceroid lipofuscinosis (NCL), two had megalencephalic leukoencephalopathy with subcortical cysts (MLC), two had ataxia with ocular motor apraxia type 1 (AOA1), one had cytochrome c oxidase deficiency, one had autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), one had Niemann-Pick type C (NPC), one had congenital disorders of glycosylation (CDG), one had adrenoleukodystrophy (ALD), and one had cobalamin transport disorder.
The diagnosis of FRDA, AT, NCL, NPC, ARSACS, MLC, ALD, AOA1, JA, l-2-hydroxyglutaric aciduria, and cobalamin transport defect was confirmed genetically. l-2-hydroxyglutaric aciduria was diagnosed based on urine organic acid analyses, cobalamin transport defect using a biochemical test for transcobalamin levels, and CDG by transferrin isoelectric focusing.
Of the 31 patients, 21 (67.7%) were from consanguineous marriages. Twenty-one patients (72.4%) had mental retardation, 8 (25.8%) had seizures, 4 (13.8%) had macrocephaly, and 3 (10.3%) had microcephaly. Electromyelography was performed in 12 of the 31 cases. Polyneuropathy was detected in seven (22.6%) patients. Two patients (6.5%) had normal or nonspecific findings on MRI, 22 (71%) had cerebellar atrophy only, and 7 (22.5%) had cerebellar atrophy combined with other changes. The characteristics of the patients are shown in [Table 1].
| Discussion|| |
In ARCAs, progressive cerebellar ataxia is usually, yet not invariably, the salient feature. However, often other neurological or non-neurological symptoms coexist. The overall estimated prevalence rate is approximately 2.2–7 per 100,000, but varies per population. In the past few years, several novel forms of ARCA have been recognized, based on identified novel loci and genes.,
FRDA and AT were reported to be the two most frequent forms of ARCA (3,5). Other forms of ARCA are much less common. The primary cause of early-onset ataxia in the Indo-European population is FRDA, which accounts for about 75% of all patients with autosomal recessive and sporadic ataxia. Most patients with the homozygotic frataxin gene (FXN) mutations fulfill the clinical diagnostic criteria for typical FRDA, and about 25% of patients have atypical FRDA, including late-onset FRDA (>25 years), FRDA with retained deep tendon reflexes, or unusually slow progression of disease. Anheim et al. studied 102 suspected ARCA cases from Eastern France. Fifty-seven patients were diagnosed by molecular analysis. Of the 57 patients, 36 were diagnosed with FRDA and 4 with AT. In another study, Rasmussen et al. analyzed 134 patients with recessive or sporadic progressive ataxia from the Mexican Mestizo (mixed) population. Of the 134 patients, 14 (10.4%) were diagnosed with FRDA. To the best of our knowledge, only one study has been reported among children with a broad spectrum of ARCAs in Turkey. Arslan et al. reported FRDA in five (12.8%) patients and AT in three (7.6%) in their study. We found FRDA in eight (25.8%) patients and AT in five (16.1%) patients. Similarly, FRDA and AT were the common etiologies in our study.
A number of leukodystrophies can present with ataxia. Macrocephaly is the most important finding of leukodystrophies. Leukodystrophy should be considered in the presence of ataxia, macrocephaly, and neuroimaging findings, and genetic analysis should be performed accordingly. Arslan et al. reported leukodystrophies in 10.2% of the 39 patients with ARCAs, including l-2-hydroxyglutaric aciduria in 5.1% and MLC in 5.1%. We detected three (9.7%) patients with l-2-hydroxyglutaric aciduria and two (6.5%) with MLC. Macrocephaly was found to be present in four of five patients with leukodystrophy.
JS is characterized by cerebellar ataxia, hypotonia, AOA1, intellectual disability, and specific mid-hindbrain malformation (“molar tooth sign,” MTS). JS is associated with MTS, a radiologic finding that includes cerebellar vermis hypoplasia or dysplasia, thick and horizontally oriented superior cerebellar peduncles, and an abnormally deep interpeduncular fossa. We diagnosed JS in three patients with ataxia. Our patients had a clinical and radiological pattern of JS, and we confirmed genetic analysis. Arslan et al. reported no JS in their study, but they reported two patients with pontocerebellar hypoplasia type 2.
ARSACS is caused by mutations of the SACS gene, characterized by late-infantile-onset spastic ataxia and other neurological features. ARSACS has a high prevalence in northeastern Quebec, Canada. Recently, several ARSACS cases have been reported from outside Canada. We reported typical clinical and neuroimaging features in a child that confirmed genetic diagnosis of ARSACS.
In patients with ataxia, neuroimaging plays an important role in diagnosis. The most common neuroimaging finding is cerebellar atrophy. On performing MRI of the brain of the patients in their study, Arslan et al. reported normal or nonspecific findings in 12 (30.8%), cerebellar atrophy only in 10 (25.6%), and cerebellar atrophy with other changes in 8 (20.5%). We performed MRI of the brain in all of our patients. The most common abnormality was vermian atrophy and/or cerebellar atrophy according to cranial MRI findings for 31 patients. In our study, 2 (6.5%) patients had normal or nonspecific findings, 22 (71%) had cerebellar atrophy only, and 7 (22.5%) had cerebellar atrophy combined with other changes.
The prevalence of hereditary ataxia can vary among countries. The consanguineous marriage is an important finding in these diseases. Consanguineous marriage is common in our country. In a study conducted in Turkey, Arslan et al. reported a rate of consanguineous marriage as 82.1%. We found 67.7% to be the rate of consanguineous marriages.
The genetic studies have increased in recent years. These genetic tests will increase the number of ARCA patients diagnosed. It will be even more important, especially where relatives are married.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Brusse E, Maat-Kievit JA, van Swieten JC. Diagnosis and management of early- and late-onset cerebellar ataxia. Clin Genet 2007;71:12-24.
Jayadev S, Bird TD. Hereditary ataxias: overview. Genet Med 2013;15:673-83.
Fogel BL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol 2007;6:245-57.
Koenig M. Rare forms of autosomal recessive neurodegenerative ataxia. Semin Pediatr Neurol 2003;10:183-92.
Vermeer S, van de Warrenburg BP, Willemsen MA, Cluitmans M, Scheffer H, Kremer BP, et al
. Autosomal recessive cerebellar ataxias: the current state of affairs. J Med Genet 2011;48:651-9.
Koht J, Tallaksen CM. Cerebellar ataxia in the eastern and southern parts of Norway. Acta Neurol Scand Suppl 2007;187:76-9.
Palau F, Espinós C. Autosomal recessive cerebellar ataxias. Orphanet J Rare Dis 2006;1:47.
Dürr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C, et al
. Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med 1996;335:1169-75.
Filla A, De Michele G, Cavalcanti F, Pianese L, Monticelli A, Campanella G, et al
. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet 1996;59:554-60.
Montermini L, Richter A, Morgan K, Justice CM, Julien D, Castellotti B, et al
. Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol 1997;41:675-82.
Anheim M, Fleury M, Monga B, Laugel V, Chaigne D, Rodier G, et al
. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics 2010;11:1-12.
Rasmussen A, Gómez M, Alonso E, Bidichandani SI. Clinical heterogeneity of recessive ataxia in the Mexican population. J Neurol Neurosurg Psychiatry 2006;77:1370-2.
Arslan EA, Göçmen R, Oğuz KK, Konuşkan GD, Serdaroğlu E, Topaloğlu H, et al
. Childhood hereditary ataxias: experience from a tertiary referral university hospital in Turkey. Acta Neurol Belg 2017;117:857-65.
Gordon HB, Letsou A, Bonkowsky JL. The leukodystrophies. Semin Neurol 2014;34:312-20.
Valente EM, Dallapiccola B, Bertini E. Joubert syndrome and related disorders. Handb Clin Neurol 2013;113:1879-88.
Bouchard JP, Barbeau A, Bouchard R, Bouchard RW. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Can J Neurol Sci 1978;5:61-9.
Ouyang Y, Segers K, Bouquiaux O, Wang FC, Janin N, Andris C, et al
. Novel SACS mutation in a Belgian family with sacsin-related ataxia. J Neurol Sci 2008;264:73-6.
Ranum LP, Lundgren JK, Schut LJ, Ahrens MJ, Perlman S, Aita J, et al
. Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia. Am J Hum Genet 1995;57:603-8.
|This article has been cited by|
||Ataxia with Ocular Apraxia Type 1 (AOA1) (APTX, W279* Mutation): Neurological, Neuropsychological, and Molecular Outlining of a Heterogenous Phenotype in Four Colombian Siblings
| ||David Aguillon, Daniel Lucia VasquezMadrigal, Sonia Moreno, Dora Hernández, Mario Isaza-Ruget, Juan Javier Lopez, Iván Landires, Virginia Nuñez-Samudio, Carlos M. Restrepo, Oscar M. Vidal, Jorge I. Vélez, Mauricio Arcos-Holzinger, Francisco Lopera, Mauricio Arcos-Burgos |
| ||Molecular Neurobiology. 2022; |
|[Pubmed] | [DOI]|